COVID-19 treatments and associated adverse reactions: The need for effective strategies to strengthen pharmacovigilance system in Lower- and middle-income countries

Ítems similars

• Adverse drug reactions reporting in Turkey and barriers: an urgent need for pharmacovigilance education
  per: Khan, Zakir, et al.
  Publicat: (2020)
• Adverse drug reaction reporting for more than a decade: The need for pharmacovigilance policy implementation in Turkey
  per: Zakir Khan, M.Phil, et al.
  Publicat: (2022-04-01)
• Physicians’ Understanding and Practices of Pharmacovigilance: Qualitative Experience from a Lower Middle-Income Country
  per: Hussain, Rabia, et al.
  Publicat: (2020)
• Anti COVID-19 Drugs: Need for More Clinical Evidence and Global Action
  per: Khan, Zakir, et al.
  Publicat: (2020)
• Strengthening medical specialisation policy in low-income and middle-income countries
  per: Sriram, Veena, et al.
  Publicat: (2020)